Nephros NEPH
NASDAQ NEPH
$4.08 -0.33 (-7.38%)
As of: Aug 21, 2026 · 3:59 PM EDT

Nephros (NEPH) Income from Continuing Operations (2010 - 2026)

Nephros (NEPH) posted quarterly Income from Continuing Operations of 29000.0 for Q1 2026, up 103.23% year-over-year from 14269.84 in Q1 2025, and down 53.23% quarter-over-quarter from 62000.0 in Q4 2025.

Nephros (NEPH) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Nephros' Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 29000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations rose 103.23% year-over-year to 29000.0; the TTM figure through Mar 2026 stood at 665000.0 (up 203.74% YoY), while the FY2025 annual figure was 1194000.0, up 1513.51% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 29000.0, down from 62000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 364000.0 in Q4 2024, with the low at 1721000.0 in Q3 2022.
  • The 5-year median for Income from Continuing Operations is 351000.0 (2023), against an average of 457235.29.
  • The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations soared 203.7% in 2024, then sank 332.21% in 2025.
  • Nephros' Income from Continuing Operations stood at 790000.0 in 2022, then jumped by 55.57% to 351000.0 in 2023, then jumped by 203.7% to 364000.0 in 2024, then tumbled by 82.97% to 62000.0 in 2025, then sank by 53.23% to 29000.0 in 2026.
  • Business Quant data shows NEPH's Income from Continuing Operations at 29000.0 in Q1 2026, 62000.0 in Q4 2025, and 337000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 823.20 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 452.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 383.43 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 139.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 147.90 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 93.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -77.90 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 135.00 Mn
10 Nephros 45.71 Mn 41.01 Mn 4.03 Mn 1.20 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.20 Mn
Mar 31, 2026 29,000.00
Dec 31, 2025 62,000.00
Sep 30, 2025 337,000.00
Jun 30, 2025 237,000.00
Mar 31, 2025 -899,000.00
Dec 31, 2024 364,000.00
Sep 30, 2024 183,000.00
Jun 30, 2024 -289,000.00
Mar 31, 2024 -208,000.00
Dec 31, 2023 -351,000.00
Sep 30, 2023 -1.03 Mn
Jun 30, 2023 -590,000.00
Mar 31, 2023 -462,000.00
Dec 31, 2022 -790,000.00
Sep 30, 2022 -1.72 Mn
Jun 30, 2022 -955,000.00
Mar 31, 2022 -1.69 Mn
Dec 31, 2021 -1.19 Mn
Sep 30, 2021 -883,000.00